FDA Inspection 1191542 — CSL Plasma Inc.

CSL Plasma Inc. — FEI 3014570107

The FDA completed an inspection of CSL Plasma Inc. on Nov 10, 2022 in Syracuse, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 10, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Syracuse, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.